Craig Astle, MD
Obstetrics & Gynecology · St George, UTNPI 1033119862
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Boston Scientific at 38.7% of the total. Reporting peaked in 2022 at $424 and has fallen 53.7% since, to $196 in 2025.
Across 82 payments — averaging $23.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$730
- AbbVie$283
- Johnson & Johnson$164
- Mayne Pharma Commercial LLC$90
- Hologic Sales And Service, LLC$78
- Evofem Biosciences, Inc.$72
- plus $470 from 16 others
What the payments were for
- Food & beverage$1,889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $730 |
| AbbVie | 16 | $283 |
| Johnson & Johnson | 6 | $164 |
| Mayne Pharma Commercial LLC | 4 | $90 |
| Hologic Sales And Service, LLC | 5 | $78 |
| Evofem Biosciences, Inc. | 4 | $72 |
| Biogen | 3 | $67 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Femselect Inc. | 1 | $47 |
| BD | 2 | $38 |
| Medtronic | 1 | $26 |
| Coloplast | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Avanos Medical | 1 | $23 |
| Eyepoint US, Inc. | 1 | $23 |
| Organon | 2 | $23 |
| Therapeuticsmd, Inc. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Roche Diagnostics Corporation | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Lupin Inc. | 1 | $18 |
How this compares
$1,889 in reported general payments places this provider in the 75th percentile of 294 obstetrics & gynecology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 109 | $3,468 |
| DottiEstradiol | 14 | $1,316 |
| ProgesteroneProgesterone, Micronized | 19 | $319 |
| Levothyroxine Sodium | 31 | $296 |
| Clobetasol Propionate | 15 | $208 |
| Ibuprofen | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in St George
- Jeffrey RogersSt George$36K
- Cassandra WeidmanSt George$5K
- Todd JarvisSt George$5K
- David TurokSalt Lake City$968K
- Scott JacobProvo$128K
- Mark StowersBountiful$121K
- Christopher HutchisonRiverton$74K
- Stephanie HendersonSandy$32K
- Kevin JensenWest Jordan$30K
- Chase PetersenLogan$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.